Market Research Logo

US Market Report for Orthopedic Cell Therapy 2017 - MedCore

US Market Report for Orthopedic Cell Therapy 2017 - MedCore

The scope of the orthopedic cell therapy market in this report covers platelet-rich plasma and concentrated bone marrow aspirate.The platelet and bone marrow concentration market consists of centrifuge equipment that separates and concentrates platelets and cells based on their various densities. The majority of companies participating in this market provide the centrifuges on loan and sell only the disposable components, such as the spin buckets. Typically, one bucket is required per procedure.

General Report Contents

  • Market Analyses include: Unit Sales, ASPs, Market Value & Growth Trends
  • Market Drivers & Limiters for each chapter segment
  • Competitive Analysis for each chapter segment
  • Section on recent mergers & acquisitions
There has been much greater interest in bone marrow concentration for use in spinal fusions compared to platelet-rich plasma. The platelet-rich plasma market, on the other hand, is expanding into soft tissue indications. While bone graft substitutes can be soaked in PRP or bone marrow concentrate as an application, the most rapidly growing application, especially for platelet-rich plasma, is for injectables. Such products are directly injected into the site, for example, in a ligament repair or wound operation.

Competition over price is the reason the market values for these segments are not growing as quickly as might be expected. Arthrex significantly brought down the ASP for the market when they introduced their ACP® platelet concentration system, but prices have now largely stabilized in the PRP segment. Test-tube-based products allow for concentration of smaller volumes; these systems reduce ASP further as customers can shift away from higher ASP disposable bucket products.


EXECUTIVE SUMMARY
U.S. ORTHOPEDIC BIOMATERIALS MARKET OVERVIEW
COMPETITIVE ANALYSIS
MARKET TRENDS
MARKET DEVELOPMENTS
PROCEDURE NUMBERS
MARKETS INCLUDED
KEY REPORT UPDATES
VERSION HISTORY
RESEARCH METHODOLOGY
1.1 RESEARCH SCOPE
1.2 IDATA’S 9-STEP METHODOLOGY
Step 1: Project Initiation & Team Selection
Step 2: Prepare Data Systems and Perform Secondary Research
Step 3: Preparation for Interviews & Questionnaire Design
Step 4: Performing Primary Research
Step 5: Research Analysis: Establishing Baseline Estimates
Step 6: Market Forecast and Analysis
Step 7: Identify Strategic Opportunities
Step 8: Final Review and Market Release
Step 9: Customer Feedback and Market Monitoring
DISEASE OVERVIEW
2.1 BASIC ANATOMY
2.1.1 Osteology and Musculoskeletal System
2.2 DISEASE PATHOLOGY AND DISORDERS
2.2.1 General Diagnostic
2.2.2 Osteoporosis
2.2.3 Osteoarthritis
2.2.4 Indication for Bone Graft Procedure
2.2.5 Indication for Cartilage Repair
2.2.6 Degenerative Disc Disease
2.3 PATIENT DEMOGRAPHICS
2.3.1 General Statistics
PRODUCT ASSESSMENT
3.1 PRODUCT PORTFOLIOS
3.1.1 Cell Therapy
3.2 REGULATORY ISSUES AND RECALLS
3.2.1 Cell Therapy
3.3 CLINICAL TRIALS
3.3.1 Cell Therapies
ORTHOPEDIC CELL THERAPY MARKET
4.1 INTRODUCTION
4.2 MARKET OVERVIEW
4.3 MARKET ANALYSIS AND FORECAST
4.3.1 Total Platelet-Rich Plasma Market
4.3.1.1 Soft Tissue Platelet-Rich Plasma Market
4.3.1.2 Orthopedic Platelet-Rich Plasma Market
4.3.1.3 Cardiac Platelet-Rich Plasma Market
4.3.1.4 Spine Platelet-Rich Plasma Market
4.3.1.5 Plastics Platelet-Rich Plasma Market
4.3.2 Total Bone Marrow Concentrate Market
4.3.2.1 Spine Bone Marrow Concentrate Market
4.3.2.2 Trauma Bone Marrow Concentrate Market
4.3.2.3 Soft Tissue Concentrated Bone Marrow Aspirate Market
4.3.2.4 Joint Concentration Bone Marrow Concentrate Market
4.4 DRIVERS AND LIMITERS
4.4.1 Market Drivers
4.4.2 Market Limiters
4.5 COMPETITIVE MARKET SHARE ANALYSIS
ABBREVIATIONS
APPENDIX II: COMPANY PRESS RELEASES
List of Charts
Chart 1 1: Orthopedic Biomaterials Market by Segment, U.S., 2013 – 2023
Chart 1 2: Orthopedic Biomaterials Market Overview, U.S., 2016 & 2023
Chart 4 1: Orthopedic Cell Therapy Market by Segment, U.S., 2013 – 2023
Chart 4 2: Orthopedic Cell Therapy Market Breakdown, U.S., 2016
Chart 4 3: Orthopedic Cell Therapy Market Breakdown, U.S., 2023
Chart 4 4: Total Platelet-Rich Plasma Market, U.S., 2013 – 2023
Chart 4 5: Soft Tissue Platelet-Rich Plasma Market, U.S., 2013 – 2023
Chart 4 6: Orthopedic Platelet-Rich Plasma Market, U.S., 2013 – 2023
Chart 4 7: Cardiac Platelet-Rich Plasma Market, U.S., 2013 – 2023
Chart 4 8: Spine Platelet-Rich Plasma Market, U.S., 2013 – 2023
Chart 4 9: Plastics Platelet-Rich Plasma Market, U.S., 2013 – 2023
Chart 4 10: Total Bone Marrow Concentrate Market, U.S., 2013 – 2023
Chart 4 11: Spine Bone Marrow Concentrate Market, U.S., 2013 – 2023
Chart 4 12: Trauma Bone Marrow Concentrate Market, U.S., 2013 – 2023
Chart 4 13: Soft Tissue Concentrated Bone Marrow Aspirate Market, U.S., 2013 – 2023
Chart 4 14: Joint Concentration Bone Marrow Concentrate Market, U.S., 2013 – 2023
Chart 4 15: Leading Competitors, Orthopedic Cell Therapy Market, U.S., 2016
List of Figures
Figure 1 1: Orthopedic Biomaterials Market Share Ranking by Segment, U.S., 2016 (1 of 2)
Figure 1 2: Orthopedic Biomaterials Market Share Ranking by Segment, U.S., 2016 (2 of 2)
Figure 1 3: Companies Researched in this Report, U.S., 2016
Figure 1 4: Factors Impacting the Orthopedic Biomaterials Market by Segment, U.S. (1 of 2)
Figure 1 5: Factors Impacting the Orthopedic Biomaterials Market by Segment, U.S. (2 of 2)
Figure 1 6: Recent Events in the Orthopedic Biomaterials Market, U.S., 2013 – 2016
Figure 1 7: Orthopedic Biomaterials Markets Covered, U.S., 2016 (1 of 2)
Figure 1 8: Orthopedic Biomaterials Markets Covered, U.S., 2016 (2 of 2)
Figure 1 9: Orthopedic Biomaterials Markets Covered, U.S., 2016(1 of 3)
Figure 3 1: Cell Therapy Products by Company
Figure 3 2: Class 2 Device Recall OnControl
Figure 3 3: Class 2 Device Recall Graft Delivery System
Figure 3 4: Autologous Bone Marrow Derived Mesenchymal Stromal Cells Transplantation (BM-MSC) for Kienbock's Disease
Figure 3 5: The Effect of Platelet Rich Plasma (PRP) on Post Operative Pain in Anterior Cruciate Ligament Reconstruction
Figure 3 6: Comparative Assessment of Intra-articular Knee Injections of Platelet-rich Plasma (PRP) and Hyaluronic Acid
Figure 3 7: Evaluation of Safety and Exploratory Efficacy of CARTISTEM®, a Cell Therapy Product for Articular Cartilage Defects
Figure 4 1: Orthopedic Cell Therapy Market by Segment, U.S., 2013 – 2023 (US$M)
Figure 4 2: Total Platelet-Rich Plasma Market, U.S., 2013 – 2023
Figure 4 3: Soft Tissue Platelet-Rich Plasma Market, U.S., 2013 – 2023
Figure 4 4: Orthopedic Platelet-Rich Plasma Market, U.S., 2013 – 2023
Figure 4 5: Cardiac Platelet-Rich Plasma Market, U.S., 2013 – 2023
Figure 4 6: Spine Platelet-Rich Plasma Market, U.S., 2013 – 2023
Figure 4 7: Plastics Platelet-Rich Plasma Market, U.S., 2013 – 2023
Figure 4 8: Total Bone Marrow Concentrate Market, U.S., 2013 – 2023
Figure 4 9: Spine Bone Marrow Concentrate Market, U.S., 2013 – 2023
Figure 4 10: Trauma Bone Marrow Concentrate Market, U.S., 2013 – 2023
Figure 4 11: Soft Tissue Concentrated Bone Marrow Aspirate Market, U.S., 2013 – 2023
Figure 4 12: Joint Concentration Bone Marrow Concentrate Market, U.S., 2013 – 2023
Figure 4 13: Drivers and Limiters, Orthopedic Cell Therapy Market, U.S., 2016
Figure 4 14: Leading Competitors, Orthopedic Cell Therapy Market, U.S., 2016
Figure 6 1: Press Release Summary

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report